Impressive acknowledgement of Benitec on the 4D website:
https://www.4dmoleculartherapeutics.com/partnerships/benitec/
"Benitec’s current clinical pipeline is focused on Hepatitis C, Hepatitis B, lung cancer and wet Age-related Macular Degeneration, as well as the orphan genetic disease, oculopharyngeal muscular dystrophy. However, ddRNAi technology has potential well beyond these conditions; it could potentially be applied to countless genes in humans and in disease-causing micro-organisms." - 4D
Add to My Watchlist
What is My Watchlist?